A critical component of nonadaptive immunity is the release of soluble mediators that affect diverse biological processes such as immune responsiveness, differentiation, and cell proliferation. In response to foreign antigens, cells of the monocyte/macrophage lineage produce a variety of peptide hormones or cytokines that bind to their cognate receptors on target cells and transduce signals to the nucleus (47) . Often the consequence of signal transduction is the modulation of gene expression, mediated by changes in the activity or amount of specific transcription factors (39) . Many viruses target infection to myeloid cells, resulting in compromise of monocyte/macrophage function. Dysregulation of the mechanisms that control cytokine production in myeloid cells may have deleterious consequences on immune responsiveness, inflammation, and viral pathogenesis.
Peripheral blood monocytes, tissue macrophages, and bone marrow-derived immature myeloblasts express the CD4 cell surface antigen, the cellular receptor for human immunodeficiency virus type 1 (HIV-1) (8, 30) , and, like T helper lymphocytes, are subject to HIV-1 infection at high frequency (1, 3, 13, 17-19, 26, 35, 45) . These cells generally do not show extensive cytopathology and thus may serve as reservoirs for viral persistence and spread to peripheral tissues (11, 46) . The distinction between a lytic versus more latent state of HIV infection is regulated by the complex interplay between HIV regulatory proteins, host cellular proteins, cis-acting DNA sequences within the HIV long * Corresponding author.
terminal repeat (LTR), and antigenic stimulation of HIVinfected cells (reviewed in reference 7). HIV pathogenesis may also be influenced by the secretion of cytokines that influence HIV multiplication (6, 11, 12, 38) . For example, monocyte-derived cytokines such as tumor necrosis factor alpha (TNF-oa) and interleukin-1 (IL-1) have been shown recently to stimulate HIV-1 transcription via activation of the transcription factor NF-KB, which binds to two recognition sequences within the HIV-1 transcriptional enhancer (9, 28, 41, 43, 44) . NF-KB may be stimulated by multiple activation mechanisms, including coinfection with other viruses, differentiation-inducing agents, and antigenic stimulation (reviewed in reference 33). It is now recognized that NF-KB is a pleiotropic mediator of gene regulation involved in the transcriptional activation of several immunoregulatory genes, cytokines, and viral promoters (33) . NF-KB exists in the cytoplasm in a latent form as a p65-pSO heterodimer coupled to an inhibitor molecule termed IKB; activation is a posttranslational event that involves dissociation from IKB and nuclear translocation of the DNA-binding activity (2, 53) . In this study, the involvement of TNF-a in HIV pathogenesis was examined in monocytic and T lymphoid cells. TNF-a mRNA production was analyzed by polymerase chain reaction (PCR) amplification in monocytic U937 cells and in a chronically HIV infected U937-derived cell line (U9-IIIB) after coinfection with Sendai virus. The (labeled I, II,  III, and IV) , the 5' and 3' untranslated regions ( XE ), and the coding regions (_) of TNF-ot (42) ; ii, the mature TNF-a mRNA and the site of primer B used in reverse transcription; iii, TNF-a cDNA and the location of primers A and B; iv, the 412-base-pair amplified product and the amplification conditions; the 94-and 85-base-pair fragments derived by PvuIL cleavage can be detected on the gel as ly-32P-end-labeled fragments (*). (B) RNA analysis. Total RNA (2 ,ug) isolated from uninduced and Sendai virus-induced U937 and U9-IIIB cells was amplified as described in Materials and Methods and analyzed on a 5% polyacrylamide gel. Lanes: 1, 5, and 9, RNA from untreated U937 cells; 2, 6, and 10, RNA from Sendai virusinduced U937 cells at 8 h p.i.; 3, 7, and 11, RNA from untreated U9-IIIB cells; 4, 8, and 12, RNA from Sendai virus-induced U9-IIIB cells at 8 h p.i. In lanes 1 to 4, TNF-a primers were used to generate a TNF-a-specific signal (412 bases); in each of these samples, 10-8 pug of SV2CAT DNA was added to the reaction after the reverse transcriptase step and coamplified with SV2CAT-specific primers to generate a signal of 303 bases. In lanes 5 WCE preparations. Whole-cell extracts (WCE) were prepared from U937 and Jurkat cells (106 cells per ml) after induction for 8 h with PMA (25 ng/ml) or TNF-a (100 U/ml). Cells were collected by centrifugation, washed once with 1 volume of cold phosphate-buffered saline, and suspended in WCE buffer (20 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid [HEPES], 0.5 mM EDTA, 0.5 mM EGTA, 0.5 mM spermidine, 0.15 mM spermine, 10% glycerol, 10 mM sodium molybdate, and 1 mM dithiothreitol) containing 0.5 mM phenylmethylsulfonyl fluoride and 1 ,ug each of pepstatin, aprotonin, and leupeptin per ml as protease inhibitors. Cells were lysed by slowly adding 2 M KCl to a final concentration of 0.5 M. Lysates were gently mixed for 30 min at 4°C, and cellular debris was removed by centrifugation (30,000 rpm, 90 min, 2°C). Supernatants were then diluted to 0.1 M KCl by adding WCE buffer (15) . Final protein concentrations were determined by the Bio-Rad protein assay.
Gel retardation assays. A 10-to 15-,ug sample of crude WCE protein, in WCE buffer (0.1 M KCl), was preincubated with S ,ug of poly(dI-dC) as nonspecific competitor DNA for 10 min on ice. -y-32P-labeled HIV enhancer probe (0.2 ng) was incubated with WCE for 20 to 30 min at room temperature. Competition assays were performed by incubating a 125-fold excess of unlabeled competitor (25 ng) with the WCE for 10 min on ice before the addition of radiolabeled probe. Samples were analyzed on native 5% acrylamide gels and run at 80 V for 1.5 to 2.5 h. Gels were dried and autoradiographed for about 15 h. Oligonucleotides were 5' end labeled with [y-32P]ATP (3, 888 Ci/mmol; ICN Radiochemicals) and polynucleotide kinase (Pharmacia) and subsequently applied to Sephadex G-50 column to remove unincorporated nucleotides.
PCR. Total cellular RNA was isolated from uninduced and induced U937 and U9-IIIB cells by a modified guanidium isothiocyanate procedure (5) and treated with 1 U of RNase-
Structure of hybrid promoter-CAT constructs. The HIV LTR, SV2CAT, and SV5P constructs were described previously (13, 27, 36) . Synthetic oligonucleotides corresponding to the P1, P2, PS, and HIV enhancer regions (see Materials and Methods) were subcloned into AccI-SphI-cleaved SV1CAT (13) . Symbols: -, mRNA start site; =, the SV40 G+C-rich region; _, the SV40
72-base-pair repeats; the HIV LTR region (-350 to +80), with the enhancer at -105 to -80 shown; lI , the IFN-P promoter (-287 to +19). The boxes in the P2(2), P1(3), KB(3), and P5 (4) plasmids indicate the number and location of the oligonucleotides. TAR, trans-activation-responsive region. 2611 Northern (RNA) blot analysis. Intracellular HIV-1 RNA was determined by analysis of HIV-1-specific sequences present in total U937 cellular RNA isolated at specific times after initial HIV-1 infection. Total RNA (20 jig) was electrophoresed in a 1.0% formaldehyde gel, transferred to nitrocellulose, and probed with an at-32P-labeled nick-translated HB10 probe, a 12.5-kilobase probe that extends over the entire length of the HIV genome (a gift from F. Wong-Staal, National Institutes of Health). The blots were air dried and exposed to Kodak X-Omat film at -70°C.
RESULTS
Stimulation of TNF-a expression in HIV-l-infected cells. To investigate the effects of HIV infection on TNF expression, oligonucleotide primers specific for the fourth exon of TNF-a (42) were used in a PCR mRNA phenotyping procedure (Fig. 1A) to characterize the amount of TNF-a mRNA   FIG. 3 . Effects of PMA and TNF-a induction on various hybrid promoters in U937 cells. The cells were transfected, by electroporation, with each of the constructs depicted in Fig. 2 . The transfected cells were induced with PMA (25 ng/ml) or TNF-a (100 U/ml) at 20 h after transfection and harvested 24 h after induction. Cell lysates were then prepared for CAT assays. Lysates (30 produced in U937 cells and chronically HIV infected U9-IIIB cells, both before and after coinfection with the Sendai paramyxovirus. Untreated U937 cells did not spontaneously express significant amounts of TNF-a mRNA (Fig. 1B, lane 1), whereas chronically HIV infected U9-IIIB cells constitutively produced a low level of TNF RNA (Fig. 1B, lane 3) . Sendai virus infection of both cell types increased the steady-state levels of TNF-a mRNA (Fig. 1B, lanes 2 and 4) . In multiple experiments, the induced U9-IIIB cells produced 5 to 10 times more TNF-a mRNA than did Sendai virusinfected U937 cells (Fig. 1C) , suggesting that TNF-a gene expression was more inducible in U9-IIIB cells. Primers to the glyceraldehyde 3-phosphate dehydrogenase (GAPDH) gene were used as an internal constitutive RNA control (Fig.  1B, lanes 5 to 8) ; these reactions were carried out separately, since GAPDH amplification interfered with the TNF amplification (data not shown). In addition, a constant amount of SV2CAT DNA (10-8 ,ug ) was added to the reaction and coamplified with TNF as an external standard for quantification (Fig. 1C) ; no interference with the TNF amplification was observed with the SV2CAT control. When reverse transcriptase was excluded from the reaction, no PCRamplified TNF-a signals were observed (Fig. 1B, lanes (Fig. 3) , phorbol ester increased SV2CAT activity about 16-fold, mediated by the TC-II (NF-KB) region of the SV40 enhancer and other PMA-inducible elements (36), whereas TNF-ao did not significantly induce the SV40 enhancer-promoter above the basal level of activity. The SV1CAT parental vector was not induced by either PMA or TNF-a, demonstrating the enhancer dependence of induction. The entire HIV LTR was induced about fivefold by PMA but was not significantly activated by TNF-ot. Cotrans- fection with an expression plasmid encoding tat-1 increased activity of the HIV LTR more than 100-fold, beyond the linear range of the assay shown. When the HIV enhancer alone was analyzed in plasmid KB(3), TNF-oa increased promoter activity 8-fold, compared with a 29-fold induction with PMA. Several significant differences were observed when the effects of TNF-a-and PMA were examined on the inducible IFN-, promoter. The IFN-P promoter was not responsive to either treatment (data not shown), and even the presence of the SV40 enhancer linked to the IFN-P promoter only moderately increased gene activity after PMA induction (Fig. 3) . This observation supports previous observations that the IFN-P promoter contains negative regulatory elements capable of silencing the activity of the SV40 enhancer (15, 21, 51, 54) .
Individual IFN-1 domains were also examined; plasmids containing the P1 and P5 regions were not induced by PMA or TNF-cx, reflecting the virus-inducible specificity of these regions (10, 16, 31) . However, the P2(2) CAT plasmid was induced 26-and 7-fold by PMA and TNF-a, respectively; these effects were virtually identical to the results observed with KB(3). These experiments confirm that the KB-containing elements of the HIV enhancer and the IFN-P promoter are equivalent regulatory elements when analyzed individually (14, 24, 34, 48) and in U937 cells are differentially induced by phorbol esters and TNF-ot. Despite the inducibility of these domains, activities of the HIV LTR and the IFN-P promoter were not increased above a basal level of activity by TNF-a treatment.
The same constructs were analyzed in Jurkat T cells (Fig.  4) . In this cellular background, a major difference in promoter activity was observed; P2 (2) and KB(3) plasmids were strongly induced (up to 100-fold) by PMA and TNF-a treatments. Most importantly, activity of the intact HIV LTR was also induced about 20-fold by TNF-cx treatment, although PMA arrowhead marks the KB protein-DNA complexes. HI enhancer containing a clustered mutation of the NF-KE mids such as SV1CAT, SV5,, P1(3), and P5( respond to either inducer, whereas SV2CAT wz induced by both compounds. These results demor T cells respond more effectively to the transcripti ing effects of TNF-ot.
Induction of NF-KcB binding by PMA and TN] were prepared from untreated or treated U937 cells to examine protein-DNA interactions withi enhancer (Fig. 5) . In U937 cells, PMA induced b factor to the HIV enhancer probe (Fig. SA , lane also induced formation of a similar protein-DNA but fivefold less complex was observed (Fig. 5A, lane 3) . The induced complexes were competed for by an excess of HIVi-fut unlabeled homologous HIV enhancer sequence and by the P-T P2 oligonucleotide (Fig. 5A, lanes 4 to 9) , whereas an HIV sP T enhancer oligonucleotide containing a clustered mutation of the NF-KB sites was unable to compete for complex formation (Fig. 5A, lanes 10 to 12) , demonstrating the specificity of binding. When Jurkat extracts were analyzed, identical inducible complexes were also formed after PMA and $ _.
TNF-a treatments, with the significant difference that TNF-a was as potent an inducer of complex formation in T cells as was phorbol ester (Fig. SB, lanes 1 to 3) . Competition assays again demonstrated that complex formation was dependent on intact NF-KB sites within the HIV enhancer (Fig. 5B, lanes 10 to 12) . To further confirm that the HIV enhancer and the P2 domain interacted with the same NF-KB proteins (Fig. SB, lanes 4 to 9) , the DNA-binding studies were repeated with use of a P2 oligonucleotide probe, and results identical to those presented in Fig. 5 (24) . TNF-ct RNA was produced at a low VOL. 64, 1990 on that a level of NF-KB-independent transcription from the HIV LTR is sufficient for virus multiplication and is consistent with the demonstration that the NF-KB-binding sites in the HIV LTR may not be absolutely required for virus infectivity (32) . In T cells, on the other hand, TNF-a produced a dramatic increase in multiplication and spread of HIV through the culture, culminating in lytic destruction of the cell population by 8 days, as compared with 16 days for the untreated, HIV-infected Jurkat cells. This dramatic alteration in the time course of HIV transmission in T cells correlates directly with the responsiveness of the HIV LTR and NF-KB-containing plasmids to TNF-a observed in the transfection studies. In vivo, HIV-infected monocytic cells may be primed in some manner by HIV infection such that subsequent antigenic stimulation of these cells leads to the production of TNF and other cytokines. TNF-a may not significantly augment HIV replication in the myeloid cell reservoir; however, T lymphoid cells, a primary target of HIV infection are highly sensitive to the T-cell-activating effects of TNF-a (27, 37, 52) , an effect mediated in part by activation of NF-KB (12, 28, 43, 44) . Continued secretion of TNF-a from activated, HIV-infected monocytic cells may contribute to viral pathogenesis by increasing the lytic spread of HIV-1 through a T-cell population.
